ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NMRA Neumora Therapeutics Inc

8.96
-0.19 (-2.08%)
Last Updated: 14:43:26
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -56.86M-114M-60.07M
Pre Tax Income -53.03M-108.46M-53.72M
Net Income -53.03M-108.73M-53.72M
Preferred Dividends 000
Basic Earnings Per Share (EPS) 000
EBIT -56.87M-114.11M-60.09M
EBITDA -56.69M-113.84M-59.92M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -237.32M-135.87M-252.1M
Pre Tax Income -237.31M-130.9M-235.66M
Net Income -237.31M-130.9M-235.93M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.239-0.256-0.575
EBIT -237.31M-135.47M-252.27M
EBITDA -236.79M-135.28M-251.43M